Pharmaceuticals: Major
Austrian companies operating in the same pharmaceuticals: major industry
The table below has Austrian companies that operate under the same industry, pharmaceuticals: major. This list helps you analyze each company’s performance, income statements, and stock activity — all in one place. Sort by key metrics to find the most expensive stocks like Eli Lilly and Company, or spot the most traded options, such as Novo Nordisk A/S Class B. Ideal for investors and traders looking to build or refine a strategy within this growing tech segment.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYCEli Lilly and Company | 945 B EUR | 1,015.6 EUR | +1.56% | 0 | 0.00 | 39.41 | 25.77 EUR | +101.28% | 0.58% | Health technology | Buy |
 JNJJohnson & Johnson | 566.53 B EUR | 236.40 EUR | +0.75% | 7 | 0.13 | 31.29 | 7.55 EUR | −4.82% | 1.96% | Health technology | Buy |
 ABBVAbbVie, Inc. | 406.14 B EUR | 230.5 EUR | −0.13% | 0 | 0.00 | 74.43 | 3.10 EUR | +73.61% | 2.59% | Health technology | Buy |
 MRKMerck & Co., Inc. | 315.51 B EUR | 129.68 EUR | +1.58% | 150 | 2.64 | 118.38 | 1.10 EUR | −80.10% | 2.29% | Health technology | Buy |
 ROGHRoche Holding Ltd | 301.47 B EUR | 395.6 EUR | +1.64% | 0 | — | 23.83 | 16.60 EUR | +32.10% | 2.96% | Health technology | Buy |
| ROGPRoche Holding Ltd | 301.47 B EUR | 385 EUR | +1.05% | 0 | 0.00 | 23.19 | 16.60 EUR | +32.10% | 2.75% | Health technology | Buy |
 NOVNNovartis AG | 223.08 B EUR | 123.30 EUR | +0.51% | 0 | 0.00 | 21.65 | 5.69 EUR | −10.40% | 3.21% | Health technology | Buy |
 NNO2Novo Nordisk A/S Class B | 166.59 B EUR | 34.790 EUR | −7.62% | 10.99 K | 1.52 | 9.95 | 3.49 EUR | +4.91% | 4.16% | Health technology | Neutral |
 PFEPfizer Inc. | 137.27 B EUR | 24.065 EUR | +0.50% | 48 | 0.02 | 36.39 | 0.66 EUR | −58.56% | 6.22% | Health technology | Neutral |
 VRTXVertex Pharmaceuticals Incorporated | 112.19 B EUR | 444.20 EUR | +0.41% | 0 | 0.00 | 29.51 | 15.05 EUR | +26.73% | 0.00% | Health technology | Buy |
 BMYSBristol-Myers Squibb Company | 112.16 B EUR | 54.94 EUR | +0.46% | 0 | — | 13.82 | 3.97 EUR | +88.93% | 3.98% | Health technology | Buy |
 SANOSanofi SA | 88.82 B EUR | 74.67 EUR | +0.20% | 513 | 1.07 | 22.43 | 3.33 EUR | −35.60% | 5.56% | Health technology | Buy |
 REGNRegeneron Pharmaceuticals, Inc. | 70.36 B EUR | 689.0 EUR | +0.61% | 0 | 0.00 | 19.45 | 35.43 EUR | +5.16% | 0.47% | Health technology | Buy |
 MRCKMerck KGaA | 56.46 B EUR | 131.85 EUR | +0.76% | 0 | 0.00 | 24.19 | 5.45 EUR | −17.22% | 1.69% | Health technology | Buy |
 TKDTakeda Pharmaceutical Co. Ltd. | 52.83 B EUR | 33.22 EUR | +0.12% | 0 | 0.00 | — | −0.57 EUR | −213.93% | 3.35% | Health technology | Buy |
 BAYNBayer AG | 47.24 B EUR | 49.05 EUR | +1.51% | 2.43 K | 0.40 | — | −1.77 EUR | +49.15% | 0.23% | Health technology | Buy |
 UCBUCB S.A. | 39.54 B EUR | 211.4 EUR | +0.33% | 0 | 0.00 | 18.70 | 11.31 EUR | +64.98% | 0.49% | Health technology | Strong buy |
 GALDGalderma Group AG | 39.05 B EUR | 171 EUR | +0.59% | 400 | 80.00 | 54.36 | 3.15 EUR | +113.32% | 0.22% | Health technology | Strong buy |
 SDZSandoz Group Ltd | 31.97 B EUR | 74.38 EUR | +2.17% | 462 | 2.13 | 58.32 | 1.28 EUR | +169.78% | 1.17% | Health technology | Buy |
 ALNYAlnylam Pharmaceuticals, Inc | 27.91 B EUR | 213.5 EUR | +0.28% | 79 | — | 41.17 | 5.19 EUR | — | 0.00% | Health technology | Buy |
 BIIBBiogen Inc. | 27.72 B EUR | 191.24 EUR | +0.75% | 0 | 0.00 | 38.68 | 4.94 EUR | −44.28% | 0.00% | Health technology | Buy |
 ZOTSZoetis, Inc. Class A | 25.69 B EUR | 61.82 EUR | −2.68% | 0 | 0.00 | 11.61 | 5.32 EUR | +7.88% | 2.93% | Health technology | Buy |
 VTRSViatris, Inc. | 16.95 B EUR | 14.950 EUR | +1.05% | 0 | 0.00 | — | −0.31 EUR | +87.33% | 2.83% | Health technology | Buy |
 IPNIpsen SA | 12.89 B EUR | 146.3 EUR | −7.58% | 0 | — | 23.68 | 6.18 EUR | +15.12% | 1.03% | Health technology | Neutral |
 RECRecordati S.p.A. | 10.88 B EUR | 52.80 EUR | −0.09% | 0 | — | 22.18 | 2.38 EUR | +22.24% | 2.54% | Health technology | Buy |
 KRKGKrka, d. d., Novo mesto | 8.1 B EUR | 260.5 EUR | 0.00% | 0 | — | 18.92 | 13.77 EUR | +10.70% | 3.50% | Health technology | Buy |
 ALKBALK-abello A/S Class B | 5.9 B EUR | 26.68 EUR | +0.53% | 0 | — | 32.68 | 0.82 EUR | +35.40% | 0.81% | Health technology | Strong buy |
 GRFGrifols, S.A. Class A | 5.67 B EUR | 9.598 EUR | −0.04% | 0 | — | 14.44 | 0.66 EUR | +51.93% | 1.97% | Health technology | Buy |
 LUNAH. Lundbeck A/S Class A | 5.58 B EUR | 5.53 EUR | +2.03% | 0 | 0.00 | 10.60 | 0.52 EUR | +11.06% | 2.84% | Health technology | No rating |
| LUNBH. Lundbeck A/S Class B | 5.58 B EUR | 5.935 EUR | +4.21% | 0 | 0.00 | 11.37 | 0.52 EUR | +11.06% | 2.70% | Health technology | Buy |
 SFZNSiegfried Holding AG | 3.49 B EUR | 77.90 EUR | +0.19% | 0 | 0.00 | 18.39 | 4.24 EUR | +12.47% | 0.55% | Health technology | Buy |
 ROVILaboratorios Farmaceuticos Rovi, S.A. | 2.92 B EUR | 57.55 EUR | −1.54% | 0 | — | 15.90 | 3.62 EUR | +39.34% | 1.35% | Health technology | Buy |
 ALMAlmirall SA | 2.27 B EUR | 10.50 EUR | 0.00% | 0 | — | 38.32 | 0.27 EUR | — | 1.45% | Health technology | Strong buy |
 DMPDermapharm Holding SE | 1.93 B EUR | 38.90 EUR | −0.38% | 0 | — | 14.10 | 2.76 EUR | +38.58% | 2.26% | Health technology | Buy |
 COPNCosmo N.V. | 975.17 M EUR | 60.0 EUR | +1.35% | 7 | 4.67 | — | −0.38 EUR | −111.41% | 3.53% | Health technology | Strong buy |
 FYBFormycon AG | 346.39 M EUR | 19.44 EUR | −1.72% | 0 | — | — | −1.42 EUR | +85.20% | 0.00% | Health technology | Strong buy |
 HPHAHeidelberg Pharma AG | 117.9 M EUR | 2.46 EUR | −0.81% | 0 | — | — | −0.71 EUR | −41.49% | 0.00% | Health technology | No rating |
 PTPNPentixapharm Holding AG | 68.02 M EUR | 1.880 EUR | +0.80% | 0 | 0.00 | — | — | — | 0.00% | Health technology | Strong buy |
 MARIMarinomed Biotech AG | 10.35 M EUR | 4.50 EUR | 0.00% | 50 | 0.45 | 0.44 | 10.15 EUR | — | 0.00% | Health technology | No rating |